Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Evosep Biolabs ApS
APS
Active
Advertising protection
CVR 44216701
Billedskærervej 15, 5230
Odense M
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 2 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Evosep Biolabs ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-3M
-3M
2024
-4M
2025
EBITDA
DKK millions
0M
-1M
-3M
-4M
-5M
-3M
2024
-4M
-33%
2025
Income statement
DKK thousands
Item
2024
2025
Gross profit
-2.808
-3.615
Staff expenses
-0
-0
EBITDA
-2.808
-3.615
Depreciation & amort.
-45
-84
EBIT
-2.853
-3.699
Net financials
-93
-262
Profit before tax
-2.946
-3.961
Tax
-0
-0
Net profit
-2.946
-3.961
Balance sheet
DKK thousands
Item
2024
2025
Total assets
1.462
701
Equity
-2.906
701
Long-term debt
0
0
Short-term debt
4.368
0
Total debt
4.368
0
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-361500000.0%
This company
2024
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2024
2025
Return on equity
-565.0%
This company
18.4%
Market median
-3171% vs market
2024
2025
Net profit margin (of gross profit)
-396100000.0%
This company
2024
2025
Asset turnover (of gross profit)
-5.16×
This company
2024
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-28 – 2024-12-31
View
PDF
More on Evosep Biolabs ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
